• 2:03:37 - 2:06:08
Emergency Sept 11, 2021 Broadcast! Epic Must See Marathon Transmission
N-acetylcysteine, Fluvoxamine and Lung Inflammation Mechanisms
Scott Miller explains the circulatory nature of COVID-19 and the importance of addressing clotting factors using N-acetylcysteine and aspirin. He also discusses the role of Fluvoxamine as an anti-serotonergic agent to decrease lung inflammation. The discussion criticizes the continued use of ventilators, which Miller and the host claim have high mortality rates for COVID-19 patients.